<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Neuroblastoma Among Omani Children: Clinical characteristics and survival outcome from a dedicated centre.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Neuroblastoma Among Omani Children: Clinical characteristics and survival outcome from a dedicated centre." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e94/8631225/cfca44bd6cf7/squmj2111-578-584f2.jpg"/> </div> <div class="text-side"> <h1>Neuroblastoma Among Omani Children: Clinical characteristics and survival outcome from a dedicated centre.</h1> <p>Haematoxylin and eosin stains of the different known histopathological entities of neuroblastoma obtained from Omani patients treated at the National Oncology Centre in Oman. A: Undifferentiated neuroblastoma at ×10 magnification showing densely packed small- to medium-sized cells that are indiscernible from a small amount of cytoplasm with vague cytoplasmic borders. B: Poorly differentiated neuroblastoma at ×4 magnification showing that ≤ 5% of the tumour cells are differentiating neuroblasts. C: Ganglioneuroblastoma or differentiating neuroblastoma at ×20 magnification showing that at least 5% of tumour cells are differentiating neuroblasts. D: Residual neuroblastoma at ×20 magnification showing mixed histological combinations.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34888077/" target="_blank">34888077</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>